About Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.
Founded
1972
CEO
Sudhir Mehta
Employees
20,341
HQ
Ahmedabad, Gujarat
Finished Products
1Sales
₹41,352.10Cr2Production linked incentive in
₹347.17Cr3Export Benefits
₹194.10Cr4Other Operating Income
₹161.11Cr5Compensation&Settlement Income
₹43.27Cr6Income from Product Regst Doss
₹17.74Cr7Government Grant Income
₹5.88CrRaw Materials
1Raw Materials Consumed
₹5,607.79Cr2Trading Purchases
₹1,280.81Cr3Purchases of Traded Goods
₹1,164.44Cr4Packing Materials
₹657.67CrAbout Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.
Founded:1972
CEO:Sudhir Mehta
Employees:20,341
HQ:Ahmedabad, Gujarat
Finished Products
1Sales
₹41,352.10Cr2Production linked incentive in
₹347.17Cr3Export Benefits
₹194.10Cr4Other Operating Income
₹161.11Cr5Compensation&Settlement Income
₹43.27Cr6Income from Product Regst Doss
₹17.74Cr7Government Grant Income
₹5.88CrRaw Materials
1Raw Materials Consumed
₹5,607.79Cr2Trading Purchases
₹1,280.81Cr3Purchases of Traded Goods
₹1,164.44Cr4Packing Materials
₹657.67CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹5,250
52W Low
₹3,481
Volume295.52K
Avg VolumeN/A
Beta0.24
Dividend Yield0.68%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
88.29x
Valuation
P/B Ratio
22.64x
Valuation
EPS
₹56.68
Valuation
Dividend Yield
0.68%
Valuation
ROE
25.49%
Profitability
ROCE
13.85%
Profitability
Revenue by Segment
Contribution & growth by business line
Generic Formulation BusinessRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
58.4%
International
41.6%
India58.4%
Other countries13.2%
USA9.7%
Brazil9.7%
Germany & Malta8.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
S
Sanofi
France
0.00% stakeN
Novo Nordisk
Denmark
0.00% stakeW
William Harvey Research Institute
United Kingdom
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
1.79x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
21.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.